Mixed dilution haemodiafiltration versus post dilution haemodiafiltration in adults with end stage kidney disease: a prospective randomised crossover trial
Completed
- Conditions
- HaemodiafiltrationEnd stage kidney diseaseRenal and Urogenital - Kidney disease
- Registration Number
- ACTRN12616000905460
- Lead Sponsor
- Princess Alexandra Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Patients with end stage kidney disease on conventional in-centre haemodialysis with dialysis session duration 4-6hr, three times per week
Exclusion Criteria
Incident haemodialysis patients (<3 months),
Temporary vascular access (HD central venous catheter)
Life expectancy <6 months
Medical instability –altered response criteria (airway, breathing, circulation, neurology)
Blood flow rate (Qb) <250mls/min
Non-adherence to prescribed treatment hours
Unable to tolerate post-dilution HDF
Residual urine output >500ml/day
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method